Clinical Trial Update: Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apatinib as a third-line therapy for advanced ovarian cancer, focusing on efficacy and safety. The update summarizes trial out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Angiogenesis Inhibitors，Ovarian Neoplasms | Phase 2 | Status: UNKNOWN